Greener Journal of Medical Sciences

Excellence and Timeliness


Choose Language


Ozele and Ozele

By Ozele, KC; Ozele, N (2022).

Greener Journal of Medical Sciences

Vol. 12(1), pp. 25-40, 2022

ISSN: 2276-7797

Copyright ©2022, the copyright of this article is retained by the author(s)







Mother -To -Child Transmission of Hepatitis B in Jos Metropolis



Ozele, Kingsley Chukwuka (MBBS, FMCOG); Ozele Nonyelim (BSC, FMLSCN)



Consultant Special Grade 1 (Obstetrics and Gynaecology) and Head Medicine and Health Services Department, National Institute for Policy and Strategic Studies Kuru Jos Plateau State, (NVRI) Vom.1

Chief Medical Laboratory Scientist Biochemistry Division National Vertinary Research Institute (NVRI) Vom.2






Article No.: 020122011

Type: Research



Background: Hepatitis B virus infection is a major public health issue worldwide and more seriously in Africa and Asia3. In Jos, like in the most parts of Nigeria, information on mother to child transmission of HBV is scarce. This study was undertaken to determine the mother- to- child transmission of hepatitis B markers at delivery.

Objectives: To determine the prevalence of HB s Ag in maternal blood and that of cord blood at  delivery at JUTH .To determine the proportion of HB s Ag positive   to HB e Ag positive on maternal and also proportion of the same markers in the cord blood.

Method: Descriptive cross sectional study

Result: The results of the study showed that the prevalence of HB S Ag among women at delivery in Jos metropolis is 12.77%. It also revealed that the prevalence of HB S Ag on cord blood is 2.2%, which is an issue of concern. Also, the proportion of HB S Ag to HB E Ag in women at delivery is 23:3. That is, 13.04% of those that are HB S Ag positive were infectious. Association was statistically significant. There was no HB E Ag positivity in all the 4 cord blood that was HB S Ag positive.

Conclusion: Jos is an area of high endemicity for hepatitis B virus infection.  In line with WHO recommendation of routine antenatal screening for HB's’Ag. for pregnant women at booking,2, routine screening for HB S Ag on all pregnant women should be introduced at the booking clinic.  


Accepted:  05/02/2022

Published: 17/02/2022


*Corresponding Author


E-mail: kingsleyozele9@



Mother - To – Child; transmission; Hepatitis-B; Jos.



Return to Content       







1.  Guberman C et al .Renal, urinary tract, gastrointestinal and dermatologic disorders in pregnancy. In: Decherney AL et al (Eds.) Current Diagnosis and treatment Obstetric and Gynaecology 10th edition. McGraw-Hill Medical Publishing Division.2007; 382-385.


2. World Health Organization (WHO). Advanced Immunization Management (AIM). Hepatitis B(cited 2005 August.); available from Assessed 15th August 2010


3.  Maddrey WC. Hepatitis B: an important public health issue. J med virol. 2000; 61(3):  362-6.


4.  Sirisena ND, Njoku MO, Idoko JA. HBsAg in patients with human immunodeficiency Virus1 (HIV-1) infection in Jos, Nigeria. Nigerian Medical Practitioner 2002; 41:18-20


5.  Kulkarimi S, Alowola FO, Wayo GG. Prevalence of hepatitis B surface antigen in Northern Nigerian blood donors. Vox Sangunis 1996; 50: 151-153.


6.  Muula AS. Tackling HIV/AIDS in Africa-another perspective. African Health 2000; 23 (1): 5-6


7.  Sylvie RR, Francis D. Hepatitis B mother to child transmission. Expert Rev. Anti-infective ther. 2004; 2(1): 133-145 


8.  Sriprakash I, Anil TP. Routine prenatal screening of Indian women for HBsAg: benefits derived versus cost. Tropical Doctor 1997; 102: 10-15


9.  Shepard TH. Catalog of teratogenic agents 9th ed. Baltimore, MD: John Hopkins University press; 1998.


10. Caruana SR, Keily HA, De silva SL, Chea l, Noun S, Saykav P. Knowledge about Hepatitis viruses in immigrant and refugees from the Mekong Region, Aust NZ. J Public Health 2005; 29: 64-68.


11. Daniel, Jos and Plateau State diff missen 2002. Available at Assessed 15th August 2010.


12. Khuroo MS, Kamili S. Aetiology, clinical course and outcome of sporadic acute viral hepatitis in pregnancy. J Viral Hepat 2003; 10: 61-9. 


13. Jaiswal SP, Jain AK, Naik G, et al. Viral Hepatitis during pregnancy. Int J Gynaecol Obstet 2001; 72: 103-8. 


14. Hieber JP, Dalton D, Shorey J, et al. Hepatitis and pregnancy. J Pediatr 1977; 91: 545-9. 


15. Adams RH, Combes B. Viral hepatitis during pregnancy. JAMA 1965; 192: 195-8. 


16. Schweitzer IL, Peters RL. Pregnancy in Hepatitis B antigen positive cirrhosis. Obstet Gynecol 1976; 48 (suppl I): 53S-56S. 


17. Infeld DS, Borkowf HI, Varma RR. Chronic persistent hepatitis and pregnancy. Gastroenterology 1979; 77: 524-7. 


18. Cheng YS. Pregnancy in liver cirrhosis and/or portal hypertension. Am J Obstet Gynecol 1977; 128: 812-22.


19. Russell MA, Craigo SD. Cirrhosis and portal hypertension in pregnancy. Semin Perinatol 1998; 22: 156-65.


20. Hiratsuka M, Minakami H, Koshizuka S, et al. Adminstration of interferon-alpha during pregnancy: effects on fetus. J Perinat Med 2000; 28: 372-6.


21. Ozaslan E, Yilmaz R, Simsek H, et al. Interferon therapy for acute hepatitis C during pregnancy. Ann Pharmacother 2002; 36: 1715-8.


22. Dando T, Plosker G. Adefovir Dipivoxil: A review of its use in chronic hepatitis B. Drugs 2003; 63: 2215-34.


23. Su GG, Pan KH, Zhao NF, et al. Efficacy and safety of lamivudine treatment for chronic hepatitis B in pregnancy. World J Gastroenterol 2004; 10: 910-1.


24. Okada K, Yamada T, Miyakawa Y, et al. Hepatitis B surface antigen in the serum of infants after deliver from asymptomatic carrier mothers. J Pediatr 1975; 87: 360-3.


25. Sweet RL. Hepatitis B infection in pregnancy. Obstet Gynecol Report 1990; 2: 128.


26. Reinus J, Leikin E. Viral hepatitis in pregnancy. Clin Liver Dis 1999; 3: 115-30.


27. Okada K, Kamiyama I, Inomata M, et al. e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants. N Engl J Med 1976; 294: 746-9.


28. Zhang SL, Yue YF, Bai GQ, et al. Mechanism of intrauterine infection of Hepatitis B virus. World J Gasroenterol 2004; 10: 437-8.  


29. Sinatra FR, Shah P, Weissman JY, et al. Perinatal transmitted acute icteric Hepatitis B in infants born to Hepatitis B surface antigen-positive anti-Hepatitis B e positive carrier mothers. Pediatrics 1982; 70: 557-9.


30. McMahon BJ, Alward WL, Hall DB, et al. Acute Hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis 1985; 151: 599-603.


31. Liu HY, Kong BH, Luo X, et al.  Study on the association between maternal-infantile vertical transmission of hepatitis B virus and human leukocyte antigen DR gene domain. Zhonghua Fu Chan Ke Za Zhi (Chinese) 2003; 38: 599-603.


32. ACOG Technical bulletin. Hepatitis in pregnancy. 174 November 1992.


33. Stevens CE, Taylor PE, Tong MJ, et al. Yeast-recombinant Hepatitis B vaccine - efficacy with hepatitis B immune globulin in prevention of perinatal Hepatitis B virus transmission. JAMA 1987; 257: 2612-6.


34. Li XM, Yang YB, Hou HY, et al. Interruption of HBV intrauterine transmission: a clinical study. World J Gastroenterol 2003; 9: 1501-3.


35. Van Zonneveld M, van Nunen AB, Neisters HG, et al. Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J Viral Hepat 2003; 10: 294-7.


36. Kazim SN, Wakil SM, Khan LA, et al. Vertical transmission of hepatitis B virus despite maternal lamivudine therapy. Lancet 2002; 359: 1488-9.


37. Wang J, Zhu Q, Zhang X. Effect of delivery mode on maternal-infant transmission of hepatitis B virus by immunoprophylaxis. Chin Med J (Engl) 2002; 115:1510-2.


38. Hill JB, Sheffield JS, Kim MJ, et al. Risk of hepatitis B transmission in breast-fed infants of chronic hepatitis B carriers. Obstet Gynecol 2002; 99: 1049-52


39. Okada K, Kamiyama I ,Inomata M et al:The e antigen and Anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants .N Engl J Med 1976 ;294:746.


40. Beasley RP, Trepo C, Steven CE. Et al: The e antigen and vertical transmission of hepatitis B surface antigen .Am J Epidemiol 1977; 105:94.


41. Steven CE, Toy PT, Tong MJ et al: Perinatal hepatitis B virus transmission in the United States :Prevention by passive –active immunization. JAMA 1985;253:1740.


42. Biswas SC, Gupta I,  Gangul NK et al :Prevalence of Hepatitis B surface antigen in pregnant mothers and its perinatal transmission .Trans R Soc Trop Med Hyg.1989;83:698.


43. Dupuy JM, Frommel D,Alagille D:Severe viral  hepatitis B in infancy.Lancet 1975;1:191.


44. Fawaz KA, Grady GF,Kaplan MM et al:Repetitive maternal-fetal transmission of fetal hepatitis B.N Engl J Med 1975;293:1357.


45. Delaplane D, Yoge  VR, Crussi F et al :Fetal hepatitis B in early infancy:The importance of identifying HB s Ag positive pregnant women and providing immunoprophylaxis for their newborn .Paediatrics 1983;72:176


46. Chang MH, Chen DS, Hsu HC et al :Maternal transmission of hepatitis B virus in childhood hepatocellular carcinoma. Cancer 1989;64:237


47. Beasley RP, Hwang LY, Lin CC et al: Hepatitis B immune globulin (HBIG) efficacy in the interruption of perinatal transmission of hepatitis B virus carrier state: Initial report of a randomized double-blind placebo-controlled trial. Lancet 1981; 2:388. 48. Beasley RP, Hwang LY, Lee GC et al: Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet 1983;2:1099.


49. Tada H, Yanagida M, Mishina J et al: Combined passive and active immunization for preventing perinatal transmission of hepatitis B virus carrier state. Pediatrics 1982;70:613.


50. Wong VCW, Ip HMH, Reesink HW et al: Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin: Double-blind randomized placebo-controlled study. Lancet 1984; 2:921.


51. Pongpipat D, Suvatte V, Assateerawatts A: Efficacy of hepatitis-B immunoglobulin and hepatitis-B vaccine in prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg. Asian Pac J Allergy Immunol 1986;4:33.


52. Schaln SW, Mazel JA, deGast GC et al: Prevention of hepatitis B infection in newborns through mass screening and delayed vaccination of all infants of mothers with hepatitis B surface antigen. Pediatrics 1989; 83:1041.


53. Poovorawan Y, Sanpavat S, Pongpunlert W et al: Protective efficacy of a recombinant DNA hepatitis B vaccine in neonates of HBe antigen-positive mothers. JAMA 1989; 269:3278.


54. Chen DS, Hsu HM, Sung JL et al: Immunization of newborns of HBsAg-positive mothers: Ag-positive mothers: A successful first step in control of hepatitis B virus in Taiwan. Hepatology 1989; 9:900.


55. London WT, O'Connell AP: Transplacental transmission of hepatitis B virus. Lancet 1:1037, 1986


56. Tang SX, Yu GL: Intrauterine infection with hepatitis B virus. Lancet 1990; 335:302.


57. Li L, Shen MH, Li YQ et al: A study of mother-infant transmission of hepatitis B virus. Shanghai, International Symposium on Liver Cancer and Hepatitis, 1986


58. Centers for Disease Control: Recommendations of the Immunization Practices Advisory Committee. Prevention of perinatal transmission of hepatitis B virus: Prenatal screening of all pregnant women for hepatitis B surface antigen MMWR Morb Mortal Wkly Rep 37:341, 1988


59. Jonas MM, Reddy RK, DeMedina M et al: Hepatitis B infection in a large municipal obstetrical population: Characterization and prevention of perinatal transmission. Am J Gastroenterol 1990; 85:277.


60. Araoye MO. Sample size determination.In :Araoye MO (ed) Research methodology with statistics for Health ans Social Sciences.Nathadex pub.,2003;6:115-121.


61. Harry TO., Bajani MD., Moses AE. Heaptitis B virus infection among blood donors and pregnant women in Maiduguri, Nigeria. East Africa Medical Journal1990;  70: 596-597.


62. Nasidi A, Harry, TO., Vyazor, SO., Numumbe, GMR., Azzan, BB., Ancinlev, VA. (1983). Prevalence of Hepatitis B infection marker in two different geographical areas of Nigeria. Proceedings of the first international conference, 12-15 December 1983, Lagos, Nigeria.


63. Luka, SA., Ibrahim, MB., Iliya, SN. Seroprevalence of hepatitis B surface antigen among pregnant women attending Ahmadu Bello University Teaching hospital, Zaria, Nigeria. Nigerian Journal of Parasitology 2008; 29(1): 38-41


64. Onakewhor, JUE., Offor, E., Okonofua, FE. Maternal and neonatal seroprevalence of Hepatitis B surface antigen (HBsAg) in Benin City. Journal of Obstetrics and Gynaecology 2001;  21(6): 583-586.


65. Akani, CI., Ojule, A C., Opurum, HC., Ejilemele, AA. Seroprevalence of HBsAg in pregnant women in Port Harcourt. Nigeria. Nigeria Postgraduate Medical Journal, 2005; 12(4): 266-270


66. Ndam IS.,Joshua IA., Luka SA.,Sadiq HO., Epidemiology of hepatitis B infection amongst pregnant women in Minna,Nigeria.Science World Journal .2008;3 :3


67. Agbaji OO,Ladep GN ,Agaba P, Badung BP, Danung ML, Imade G et al. Prevalence and characteristics of Hepatitis B Surface Antigenaemia amongst HIV infected Patient in Jos, Nigeria. Hungarian Medical Journal ,2008;2(1.9):77-82


68. Sirisena ND, Njoku M, Idoko JA . Hepatitis B Surface antigenaemia in patient with HIV 1 infection in Jos , Nigeria .Nigeria Medical Practitioner 2002;41:18-20.


69. Jombo GTA, Egah DZ, Banwat EB. Hepatitis B virus infection in a rural settlement in Northern Nigeria. Niger J med 2005; 4: 524-428.


70. Mbaawuga EM, Enenebeaku MNO, Okopi JA,  Damen JG. Hepatitis B virus (HBV) infection among pregnant women in Markudi, Nigeria. Afr. J. Biomed. Res. 2000; 11: 155-159.


71. Ameer A, Abdul R, Ghulam QKK. Hepatitis B markers; its transmission in newborn from mothers. Professional med J 2007; 14(2): 307-311 


72. Zuberi SJ, Lodi P. Pathern of HB s Ag/ HB e Ag antigenaemia in pregnant women. JAMA 1989; 39: 160.



Cite this Article: Ozele, KC; Ozele, N (2022). Mother -To -Child Transmission of Hepatitis B in Jos Metropolis. Greener Journal of Medical Sciences, 12(1): 25-40.


Call for Papers

Call for Scholarly Articles

Authors from around the world are invited to send scholarly articles that suits the scope of this journal. The journal is currently open to submissions and will process and publish articles monthly in two yearly issues.

The journal is centered on quality and goes about its processes in a very timely fashion. Seasoned editors/reviewers will be consulted to review each article(s), profer quality evaluations and polish the articles with expertise before publication.

Simply send your article(s) as an e-mail attachment to or



Login Form

Other Journals